Get startedLog in
    Picture of Strides Pharma Science logo

    STAR — Strides Pharma Science Cashflow Statement

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareAdventurousMid CapHigh Flyer
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Strides Pharma Science, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    2025
    March 31st
    2026
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSPRESS
    Standards:
    IAS
    IAS
    IAS
    IAS    		—
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-6,525-2,862-1,1694,8696,687
    Depreciation
    Non-Cash Items3,4934,5756,5181,01929.9
    Discontinued Operations
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital-1,876-3,705-546-967-1,716
    Change in Accounts Receivable
    Change in Inventories
    Change in Accounts Payable
    Other Operating Cash Flow
    Cash from Operating Activities-2,5784417,0096,8447,025
    Capital Expenditures-1,434-949-1,182-2,425-4,179
    Purchase of Fixed Assets
    Other Investing Cash Flow Items2473,974-3211,5282,449
    Acquisition of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Change in Net Investments
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-1,1873,025-1,503-897-1,730
    Financing Cash Flow Items-1,538-2,242-2,922-2,405-1,679
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities4,213-2,139-6,933-6,426-4,534
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash4491,328-1,425-485761